KenYYonedaMD
Pulmonology • Sacramento, CACritical Care Medicine, Pleural Disease
Professor, Internal Medicine, UC, Davis School of Medicine
Dr. Yoneda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4150 V Street, Suite 3400
University Of California Davis Health System
Sacramento, CA 95817Phone+1 916-734-3565Fax+1 916-734-7924
Education & Training
University of California Davis HealthFellowship, Pulmonary Disease and Critical Care Medicine, 1993 - 1997
University of Kansas School of MedicineResidency, Internal Medicine, 1985 - 1988
Northwestern University The Feinberg School of MedicineClass of 1985
Certifications & Licensure
CA State Medical License 1993 - 2024
NV State Medical License 1988 - 1997- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- The First Therapeutic Intervention in Malignant Pleural Effusion Trial Start of enrollment: 2009 Apr 01
Publications & Presentations
PubMed
- 92 citationsMevalonate Cascade Inhibition by Simvastatin Induces the Intrinsic Apoptosis Pathway via Depletion of Isoprenoids in Tumor Cells.Javad Alizadeh, Amir A. Zeki, Nima Mirzaei, Sandipan Tewary, Adel Rezaei Moghadam
Scientific Reports. 2017-03-27 - 1 citationsSimvastatin Overcomes Resistance to Tyrosine Kinase Inhibitors in Patient-derived, Oncogene-driven Lung Adenocarcinoma Models.Weijie Ma, Weijie Ma, Sixi Wei, Qianping Li, Jie Zeng
Molecular Cancer Therapeutics. 2024-05-02 - 67 citationsMolecular testing strategies in non-small cell lung cancer: optimizing the diagnostic journeyJeffrey P. Gregg, Tianhong Li, Ken Y. Yoneda
Translational Lung Cancer Research. 2019-06-01
Journal Articles
- Bronchial Thermoplasty: A Decade of Experience: State of the ArtD Kyle Hogarth, Laren D Tan, Ken Y Yoneda, Samuel Louie, ScienceDirect
Press Mentions
‘For Me, It Was a Miracle’: Novel Treatment Improves Quality of Life for COPD PatientAugust 29th, 2022- UCSB Researchers Discover Superior Culture Medium for Bacterial Testing, Along with New Insights into Antimicrobial ResistanceJune 14th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
